Ankaferd blood stopper as a new strategy to avoid early complications after transradial procedures: A randomized clinical trial.

MLA

Gorgulu, Sevket, et al. “Ankaferd Blood Stopper as a New Strategy to Avoid Early Complications after Transradial Procedures: A Randomized Clinical Trial.” Journal of Interventional Cardiology, vol. 31, no. 4, Aug. 2018, pp. 511–17. EBSCOhost, https://doi.org/10.1111/joic.12514.

APA

Gorgulu, S., Norgaz, T., & Sipahi, I. (2018). Ankaferd blood stopper as a new strategy to avoid early complications after transradial procedures: A randomized clinical trial. Journal of Interventional Cardiology, 31(4), 511–517. https://doi.org/10.1111/joic.12514

Chicago

Gorgulu, Sevket, Tugrul Norgaz, and Ilke Sipahi. 2018. “Ankaferd Blood Stopper as a New Strategy to Avoid Early Complications after Transradial Procedures: A Randomized Clinical Trial.” Journal of Interventional Cardiology 31 (4): 511–17. doi:10.1111/joic.12514.